Skip to content

Dopamine receptor and dopamine transporter in obesity: A meta-analysis

Document Type
Publications · Journal Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q4Scopus Q3
Journal
SYNAPSE77(1) · 2023
Citation
Web of Science 6Scopus 5
FWCI (Scopus)
0.37
JCR IF
JCR 2022 2.3
ISSN
0887-4476

Authors

  1. Pak, KyoungjuneFirst authorCorresponding authorPusan Natl Univ Hosp, Dept Nucl Med, 179 Gudeok Ro, Busan 49241, South Korea
  2. Seok, Ju WonCorresponding authorChung Ang Univ, Dept Nucl Med, Coll Med, 102 Heukseok Ro, Seoul, South Korea
  3. Lee, Myung JunPusan Natl Univ Hosp, Biomed Res Inst, 179 Gudeok Ro, Busan 49241, South Korea
  4. Kim, KeunyoungPusan Natl Univ Hosp, Dept Nucl Med, 179 Gudeok Ro, Busan 49241, South Korea
  5. Kim, In-jooPusan Natl Univ Hosp, Dept Nucl Med, 179 Gudeok Ro, Busan 49241, South Korea

Abstract

The brain plays a major role in controlling the desire to eat. This meta-analysis aimed to assess the association between dopamine receptor (DR) availability and dopamine transporter (DAT) availability, measured using positron emission tomography, and obesity. We performed a systematic search of MEDLINE (from inception to November 2020) and EMBASE (from inception to November 2020) for articles published in English using the keywords dopamine receptor, dopamine transporter, obesity, and neuroimaging. Body mass index (BMI) and the corresponding binding potential (BPND) were extracted from figures in each study using Engauge Digitizer, version 12.1, and plotted for radiopharmaceuticals and regions of interest (ROIs). Five studies involving 119 subjects with DR and five studies including 421 subjects with DAT were eligible for inclusion in this study. In overweight or obese subjects with BMI of 25 kg/m(2) or higher, DR availability from C-11-Racloprie was negatively associated with BMI. However, DR availability from C-11-PHNO was positively associated with BMI. DAT ratio was calculated after dividing DAT availabilities of overweight/obese BMI with mean DAT availabilities of normal BMI. The association between DAT ratio and BMI was not significant regardless of radiopharmaceuticals. In conclusion, dopamine plays a main role in the reward system with regard to obesity. Overweight and obese subjects had negative association between DR availability from C-11-Raclopride and BMI. However, the association of DR availability with BMI was dependent on radiopharmaceuticals. DAT availability did not show the significant relationship with BMI regardless of radiopharmaceuticals.

Keywords

dopamine receptorsdopamine plasma membrane transport proteinsobesityneuroimagingBODY-MASS INDEXHEALTHY-VOLUNTEERSBRAINAVAILABILITYBINDINGRELEASEI-123-FP-CITINFLAMMATIONINDIVIDUALSMECHANISMS

Identifiers

Scopus EID
2-s2.0-85138723040
WoS UID
000860252000001